LysGH15 kills Staphylococcus aureus without being affected by the humoral immune response or inducing inflammation

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Zhang, Lei ^a   Li, Dong ^a   Li, Xinwei ^a   Hu, Liyuan ^a   Cheng, Mengjun ^a   Xia, Feifei ^a   Gong, Pengjuan ^a   Wang, Bin ^a   Ge, Jinli ^a   Zhang, Hao ^a   Cai, Ruopeng ^a   Wang, Yanmei ^a   Sun, Changjiang ^a   Feng, Xin ^a   Lei, Liancheng ^a   Han, Wenyu ^a,b   Gu, Jingmin ^a  

^a JILIN UNIVERSITY   (China)

^b YANGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; LYSIN, GASTROPODA; MUCOPROTEIN;

ANIMAL; BAGG ALBINO MOUSE; CHEMICALLY INDUCED; DRUG EFFECT; FEMALE; HUMORAL IMMUNITY; INFLAMMATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOUSE; STAPHYLOCOCCUS INFECTION; STAPHYLOCOCCUS PHAGE;

ANIMALS; ANTI-BACTERIAL AGENTS; FEMALE; IMMUNITY, HUMORAL; INFLAMMATION; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICE; MICE, INBRED BALB C; MUCOPROTEINS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS PHAGES;

EID: 84977612652     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep29344     Document Type: Article

References (44)

1. Blodkamp, S. et al. In vitro activity of human and animal cathelicidins against livestock-associated methicillin-resistant Staphylococcus aureus. Veterinary microbiology, doi: 10.1016/j.vetmic.2015.09.018 (2015).
2. Knox, J., Uhlemann, A. C. & Lowy, F. D. Staphylococcus aureus infections: transmission within households and the community. Trends Microbiol 23, 437-444, doi: 10.1016/j.tim.2015.03.007 (2015).
3. Miller, L. G. et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. The New England journal of medicine 352, 1445-1453, doi: 10.1056/NEJMoa042683 (2005).
4. Tenover, F. C. et al. Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania. Antimicrobial agents and chemotherapy 48, 275-280, doi: 10.1128/AAC.48.1.275-280.2004 (2004).
5. Weigel, L. M. et al. Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science 302, 1569-1571, doi: 10.1126/science.1090956 (2003).
6. Neu, H. C. The crisis in antibiotic resistance. Science 257, 1064-1073, doi: 10.1126/science.257.5073.1064 (1992).
7. Enright, M. C. The evolution of a resistant pathogen-the case of MRSA. Current opinion in pharmacology 3, 474-479 (2003).
8. Thammavongsa, V., Kim, H. K., Missiakas, D. & Schneewind, O. Staphylococcal manipulation of host immune responses. Nat Rev Microbiol 13, 529-543, doi: 10.1038/nrmicro3521 (2015).
9. Obeso, J. M., Martinez, B., Rodriguez, A. & Garcia, P. Lytic activity of the recombinant staphylococcal bacteriophage PhiH5 endolysin active against Staphylococcus aureus in milk. International journal of food microbiology 128, 212-218, doi: 10.1016/j. ijfoodmicro.2008.08.010 (2008).
10. Witzenrath, M. et al. Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia. Critical care medicine 37, 642-649, doi: 10.1097/CCM.0b013e31819586a6 (2009).
11. Becker, S. C. et al. LysK CHAP endopeptidase domain is required for lysis of live staphylococcal cells. FEMS Microbiol Lett 294, 52-60, doi: 10.1111/j.1574-6968.2009.01541.x (2009).
12. Nelson, D., Loomis, L. & Fischetti, V. A. Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme. Proc Natl Acad Sci USA 98, 4107-4112, doi: 10.1073/pnas.061038398 (2001).
13. Loeffler, J. M., Nelson, D. & Fischetti, V. A. Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase. Science 294, 2170-2172, doi: 10.1126/science.1066869 (2001).
14. Schuch, R., Nelson, D. & Fischetti, V. A. A bacteriolytic agent that detects and kills Bacillus anthracis. Nature 418, 884-889, doi: 10.1038/nature01026 (2002).
15. Schmelcher, M., Donovan, D. M. & Loessner, M. J. Bacteriophage endolysins as novel antimicrobials. Future microbiology 7, 1147-1171, doi: 10.2217/fmb.12.97 (2012).
16. Gu, J. et al. LysGH15, a novel bacteriophage lysin, protects a murine bacteremia model efficiently against lethal methicillin-resistant Staphylococcus aureus infection. J Clin Microbiol 49, 111-117, doi: 10.1128/JCM.01144-10 (2011).
17. Gu, J. et al. LysGH15 reduces the inflammation caused by lethal methicillin-resistant Staphylococcus aureus infection in mice. Bioengineered bugs 2, 96-99, doi: 10.4161/bbug.2.2.14883 (2011).
18. Gu, J. et al. LysGH15B, the SH3b domain of staphylococcal phage endolysin LysGH15, retains high affinity to staphylococci. Current microbiology 63, 538-542, doi: 10.1007/s00284-011-0018-y (2011).
19. Gu, J. et al. Structural and biochemical characterization reveals LysGH15 as an unprecedented EF-hand-like calcium-binding phage lysin. PLoS pathogens 10, e1004109, doi: 10.1371/journal.ppat.1004109 (2014).
20. Daniel, A. et al. Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus. Antimicrobial agents and chemotherapy 54, 1603-1612, doi: 10.1128/AAC.01625-09 (2010).
21. Pastagia, M. et al. A novel chimeric lysin shows superiority to mupirocin for skin decolonization of methicillin-resistant and-sensitive Staphylococcus aureus strains. Antimicrobial agents and chemotherapy 55, 738-744, doi: 10.1128/AAC.00890-10 (2011).
22. Fischetti, V. A. Bacteriophage lysins as effective antibacterials. Current opinion in microbiology 11, 393-400, doi: 10.1016/j. mib.2008.09.012 (2008).
23. Bellanger, X., Guilloteau, H., Bonot, S. & Merlin, C. Demonstrating plasmid-based horizontal gene transfer in complex environmental matrices: a practical approach for a critical review. The Science of the total environment 493, 872-882, doi: 10.1016/j. scitotenv.2014.06.070 (2014).
24. Jutkina, J., Rutgersson, C., Flach, C. F. & Joakim Larsson, D. G. An assay for determining minimal concentrations of antibiotics that drive horizontal transfer of resistance. The Science of the total environment 548-549, 131-138, doi: 10.1016/j.scitotenv.2016.01.044 (2016).
25. Kim, S. et al. Transfer of antibiotic resistance plasmids in pure and activated sludge cultures in the presence of environmentally representative micro-contaminant concentrations. The Science of the total environment 468-469, 813-820, doi: 10.1016/j. scitotenv.2013.08.100 (2014).
26. Qiu, Z. et al. Nanoalumina promotes the horizontal transfer of multiresistance genes mediated by plasmids across genera. Proceedings of the National Academy of Sciences of the United States of America 109, 4944-4949, doi: 10.1073/pnas.1107254109 (2012).
27. Gilmer, D. B., Schmitz, J. E., Euler, C. W. & Fischetti, V. A. Novel bacteriophage lysin with broad lytic activity protects against mixed infection by Streptococcus pyogenes and methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 57, 2743-2750, doi: 10.1128/AAC.02526-12 (2013).
28. Jado, I. et al. Phage lytic enzymes as therapy for antibiotic-resistant Streptococcus pneumoniae infection in a murine sepsis model. The Journal of antimicrobial chemotherapy 52, 967-973, doi: 10.1093/jac/dkg485 (2003).
29. Muller, S. et al. Poorly Cross-Linked Peptidoglycan in MRSA Due to mecA Induction Activates the Inflammasome and Exacerbates Immunopathology. Cell host & microbe 18, 604-612, doi: 10.1016/j.chom.2015.10.011 (2015).
30. Loeffler, J. M., Djurkovic, S. & Fischetti, V. A. Phage lytic enzyme Cpl-1 as a novel antimicrobial for pneumococcal bacteremia. Infection and immunity 71, 6199-6204 (2003).
31. Rashel, M. et al. Efficient elimination of multidrug-resistant Staphylococcus aureus by cloned lysin derived from bacteriophage phi MR11. The Journal of infectious diseases 196, 1237-1247, doi: 10.1086/521305 (2007).
32. Loessner, M. J., Kramer, K., Ebel, F. & Scherer, S. C-terminal domains of Listeria monocytogenes bacteriophage murein hydrolases determine specific recognition and high-affinity binding to bacterial cell wall carbohydrates. Molecular microbiology 44, 335-349 (2002).
33. Greenlee-Wacker, M. C. et al. Phagocytosis of Staphylococcus aureus by human neutrophils prevents macrophage efferocytosis and induces programmed necrosis. Journal of immunology 192, 4709-4717, doi: 10.4049/jimmunol.1302692 (2014).
34. Xia, F. et al. Combination Therapy of LysGH15 and Apigenin as a New Strategy for Treating Pneumonia Caused by Staphylococcus aureus. Applied and environmental microbiology 82, 87-94, doi: 10.1128/AEM.02581-15 (2015).
35. Galli, S. J. The Mast Cell-IgE Paradox: From Homeostasis to Anaphylaxis. The American journal of pathology 186, 212-224, doi: 10.1016/j.ajpath.2015.07.025 (2016).
36. Urb, M. & Sheppard, D. C. The role of mast cells in the defence against pathogens. PLoS pathogens 8, e1002619, doi: 10.1371/journal. ppat.1002619 (2012).
37. Wiegand, I., Hilpert, K. & Hancock, R. E. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nature protocols 3, 163-175, doi: 10.1038/nprot.2007.521 (2008).
38. Rodriguez-Rubio, L. et al. The phage lytic proteins from the Staphylococcus aureus bacteriophage vB-SauS-phiIPLA88 display multiple active catalytic domains and do not trigger staphylococcal resistance. PloS one 8, e64671, doi: 10.1371/journal. pone.0064671 (2013).
39. Maruyama, K. et al. ELISA-Based Detection System for Protein S K196E Mutation, a Genetic Risk Factor for Venous Thromboembolism. PloS one 10, e0133196, doi: 10.1371/journal.pone.0133196 (2015).
40. Meng, F. et al. Production and characterization of a monoclonal antibody against spike protein of transmissible gastroenteritis virus. Hybridoma 29, 345-350, doi: 10.1089/hyb.2010.0009 (2010).
41. Pleckaityte, M. et al. Construction of polyomavirus-derived pseudotype virus-like particles displaying a functionally active neutralizing antibody against hepatitis B virus surface antigen. BMC biotechnology 15, 85, doi: 10.1186/s12896-015-0203-3 (2015).
42. Martin, G. G. et al. Structure and function of the sterol carrier protein-2 N-terminal presequence. Biochemistry 47, 5915-5934, doi: 10.1021/bi800251e (2008).
43. Entenza, J. M., Loeffler, J. M., Grandgirard, D., Fischetti, V. A. & Moreillon, P. Therapeutic effects of bacteriophage Cpl-1 lysin against Streptococcus pneumoniae endocarditis in rats. Antimicrobial agents and chemotherapy 49, 4789-4792, doi: 10.1128/ AAC.49.11.4789-4792.2005 (2005).
44. Cui, Z. et al. Mannose-modified chitosan microspheres enhance OprF-OprI-mediated protection of mice against Pseudomonas aeruginosa infection via induction of mucosal immunity. Applied microbiology and biotechnology 99, 667-680, doi: 10.1007/s00253-014-6147-z (2015).